MSD

News

A new treatment regimen for advanced bladder cancer combining MSD's Keytruda with Astellas' Padcev has been given the green light for NHS use.

News

MSD's plan to reduce its headcount by around 6,000 looks like it will start at its headquarters in Rahway, New Jersey.

News

MSD is embarking on a $3bn cost-reduction drive to prepare for the loss of patent protection for cancer blockbuster Keytruda.

News

LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million.

News

MSD has agreed a $10bn takeover offer for respiratory drug specialist Verona Pharma and its fast-growing COPD therapy Ohtuvayre.

News

MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.